New nanofactories could lead to medicines, vitamins and more being made at lower costs

Bacterial microcompartments are made out of proteins, represented by the colorful, wavy lines in the top figure. These icosahedral shells are empty, as shown below, and Spartan researchers have helped show how they can add enzymes of choice inside.

Credit: Kerfeld Lab/PNAS

Thanks to a lesser-known feature of microbiology, Michigan State University researchers have helped open a door that could lead to medicines, vitamins and more being made at lower costs and with improved efficiency.

The international research team, led by Henning Kirst and Cheryl Kerfeld have repurposed what are known as bacterial microcompartments and programmed them to produce valuable chemicals from inexpensive starting ingredients.

The team recently published its work in the journal Proceedings of the National Academy of Sciences.

“The microcompartments, they’re like nanoreactors or nanofactories,” said Kirst, a senior research associate in Kerfeld’s lab, which operates at both MSU and Lawrence Berkeley National Laboratory.

Kirst, Kerfeld and their teammates saw the microcompartments as an opportunity to take important chemical reactions to the next level. Over the past few decades, researchers have harnessed the power of enzymes found in bacteria to create valuable chemical products including biofuels and medicines.

In those industrial applications, though, chemists often rely on the entire microorganism to produce the desired compound, which Kirst said can lead to complications and inefficiencies.

“The analogy we use is it’s like a house. If you have reactions running all over the place, it can get very complex,” Kirst said. “Imagine you start taking a shower in the basement, but then you need to go to the second floor to get shampoo, then back to the basement to finish showering and then to the first floor to get your towel. It’s just very inefficient.”

In the case of the microorganisms, the bacteria might make one ingredient on one side of its cell, while the specific enzyme that uses that ingredient to make the final product is on the other side. Then, even if that ingredient can make the trip across the cell, there are other enzymes along the way that might snatch it up and use it for something else.

The enzymes, however, live in bacterial microcompartments, which are like rooms within the house that is the cell. The Spartans and their colleagues showed they could engineer microcompartments to optimize a specific reaction, bringing the requisite enzymes and ingredients together in the same, smaller space, rather than having them spread out.

“We’re putting everything we need for a task in the same room,” Kirst said. “The compartmentalization gives us a lot more control and enhances efficiency.”

“It’s like working in an efficiency apartment versus the Spelling Manor [the Spelling Manor is a huge property in Los Angeles — it has over 100 rooms and more than 50,000 square feet],” said Kerfeld, a Hannah Distinguished Professor in MSU Department of Biochemistry and Molecular Biology in the College of Natural Science and a faculty member in the MSU-DOE Plant Research Laboratory, which is supported by the U.S. Department of Energy.

As a proof-of-concept, the team engineered a microcompartment system that could turn the simple and inexpensive compounds formate and acetate into pyruvate.

“Pyruvate is also a relatively simple precursor for virtually anything biology can make — for example, pharmaceuticals, vitamins and flavorings,” Kirst said. “But we think the whole principal is very generalizable to many other metabolic pathways that would be interesting to explore.”

And they aren’t the only ones who think so.

“The system described here can be used as a platform in ambitious engineering projects,” wrote Volker Müller in a commentary about the research. Müller is the head of the Department of Microbiology and Bioenergetics at Goethe University Frankfurt and was not involved in the project.

“This is exciting and paves the road to use the strategy to engineer (bacterial microcompartments) for the production of various compounds from cheap substrates,” he said.

Bacterial microcompartments are similar to the organelles or tiny “organs” found in the cells of eukaryotes, which include plants, humans and other animals. Although they’re found in many different types of bacteria, where they help carry out a multitude of reactions, they’re still relatively new to science. It took the advent of high-resolution electron microscopy and affordable gene sequencing for researchers to appreciate how widespread and versatile these compartments are, Kerfeld explained.

Working with researchers at the Max Planck Institute of Molecular Plant Physiology, the Spartan researchers have bolstered that versatility. They’ve shown how scientists can create versions of these compartments that aren’t found in nature.

“We can take the architecture for the compartment and put in a totally new type of reaction,” Kerfeld said. “This strategy could be applied in lots of different ways for a lot of different uses, even uses that aren’t compatible with bacteria.”

“I think that’s the major accomplishment,” Kirst said. “We took a big step toward making a synthetic bacterial organelle.”

Original Article: Building ‘nanofactories’ to help make medicines and more

Go deeper with Bing News on:

Synthetic bacterial organelle

Researchers advance understanding of why cell parts look the way they do
Scientists have long understood that parts of cells, called organelles, evolved to have certain shapes and sizes because their forms are closely related to how they function. Now, Johns Hopkins ...
Cannabeginners: What Are Synthetic Cannabinoids?
Synthetic cannabinoids generally act as agonists (causing an interaction) with the CB1 receptor rather than antagonists (blocking an interaction). According to the National Institute on Drug Abuse ...
Why Lab-Grown Meat Is Truly Real Meat—and More Insights From a Scientist on the Cutting Edge
The very real roast chicken or hamburger you feast on in the future may come from lab-cultivated cells and not from a barnyard animal.
Phage Therapy To Defeat Superbugs Is Taking Off
Shrapnel in her leg left her vulnerable to infection with one of the world’s most drug-resistant bacteria ... phage therapy, and synthetic biology with CRISPR-Cas are all coming together ...
Scientists develop a model human gut microbiome
In the current study, scientists have developed and characterized a synthetic bacterial community representing the most common microbial species found in the endogenous human gut microbiota.

Go deeper with Google Headlines on:

Synthetic bacterial organelle

[google_news title=”” keyword=”synthetic bacterial organelle” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]

Go deeper with Bing News on:

Nanofactories

The Handover by David Runciman review – is the future out of our control?
One projection involved an AI system building covert “nanofactories producing target-seeking mosquito-like robots [which] might then burgeon forth simultaneously from every square metre of the ...
Nanotech set to change the world
If the dream of molecular manufacturing and "nanofactories" comes true, as many scientists believe it will, there could be numerous social, economic, and even existential risks. For Nanotech BC ...
Nano Tomorrows - Scenario 3
However, 3MP-Mfg decided that nanofactories were the only viable solution to the recovery of domestic manufacturing, and those of us who had followed the idea since Drexler's Engines were treated to ...
Ten things you should know about nanotechnology
Early proponents of molecular manufacturing used the term to describe nanoscale machinery – motors, computers, autonomous robots (even self-replicating ones), and personal nanofactories a la Star Trek ...
Novel Molecular Architectures Using Nature’s Nanofactories
Summary: Enzymes are useful for the preparation of a wide variety of polymers. A wide variety of substrates may be used for synthesis; Methodology exceptionally flexible; Demonstrated drug delivery ...